Sourcing the Bioperfectus SARS-CoV-2 Variant Omicron Real Time PCR Kit

SARS-CoV-2 Variant Omicron Real Time PCR Kit

Variant surveillance and diagnostic labs need assays whose declared targets and regulatory status can be checked against local requirements before adoption. The Bioperfectus SARS-CoV-2 Variant Omicron Real Time PCR Kit is listed with CE-IVD status and a defined target set.

The stated targets are ORF1ab and mutations E484A, N679K, L981F, and H655Y of the S gene. That makes the kit’s identity specific to Omicron-related detection rather than a generic SARS-CoV-2 assay.

The supplied specifications list a limit of detection of 500 copies/mL and 100% coincidence with internal positive and negative references. Those figures describe the stated reference comparison, not an independent clinical evaluation.

Sample types include nasopharyngeal swabs, throat swabs, and sputum specimens. Laboratories must confirm that collection, transport, extraction, and amplification workflows match the instructions for use.

Procurement should therefore focus on documentation and fit. Scientific China lists sourcing, configuration, minimum order quantity, and logistics support as quotation variables, alongside package size or system configuration.

Buyers should also verify local regulatory acceptance, expiry and storage requirements, and whether existing thermocyclers and extraction systems are supported, because the input does not confirm those details.

The kit’s practical value lies in traceable target definition and documented regulatory status, not in broad claims. A sourcing decision should rest on verified instructions-for-use alignment and a complete evidence file.

Why it matters:
For labs and distributors, this Omicron PCR kit is a document-sensitive purchase. Confirm target set, CE-IVD status, workflow compatibility, and supplier terms before committing.

View Product →